dr. chandra on the incidence of targetable mutations in melanoma
Published 4 years ago • 188 plays • Length 2:01Download video MP4
Download video MP3
Similar videos
-
6:03
mutations of clinical significance in melanoma
-
5:59
targeting nras mutations in metastatic melanoma
-
1:19
expert discusses mutations in melanoma
-
1:04
dr. schuchter on testing for a braf mutation in melanoma
-
27:28
advances in therapy for braf-mutant melanoma
-
1:14
dr. chapman on targeted treatments for non-traditional mutations in melanoma
-
22:44
braf targeted therapy - melanoma education symposium, peter boasberg md
-
54:13
dr araz marachelian, history of nant & current trials
-
10:08
emerging approaches for braf-mutant metastatic melanoma
-
0:58
dr. sullivan on targeted therapy for braf-mutant melanoma
-
2:10
about mutations in advanced (unresectable or metastatic) melanoma
-
1:02
dr. polsky on the clinical validity of ctdna in braf-mutant melanoma
-
12:57
aim at melanoma - mutations & genetic factors
-
6:22
braf and mek in melanoma
-
20:35
hitting the mark with targeted therapy: braf, nras, ckit, etc...sullivan
-
6:33
treatment of braf-mutant metastatic melanoma
-
8:13
case 2: frontline decisions in stage iv braf-mutant melanoma
-
6:08
braf-mutant melanoma: frontline decisions
-
9:49
options for nras-mutant melanoma